IR@PKUHSC  > 北京大学临床肿瘤学院  > 病理科
学科主题临床医学
HER2 Status in Gastric and Gastroesophageal Junction Cancer Assessed by Local and Central Laboratories: Chinese Results of the HER-EAGLE Study
Huang, Dan1,2; Lu, Ning3; Fan, Qinhe4; Sheng, Weiqi1,2; Bu, Hong5; Jin, Xiaolong6; Li, Guimei7; Liu, Yanhui8; Li, Xianghong9; Sun, Wenyong10; Zhang, Huizhong11; Li, Xiaobing12; Zhou, Zongguang13; Yan, Min14,15; Wang, Xuan16; Sha, Weihong17; Ji, Jiafu18; Cheng, Xiangdong19; Zhou, Zhiwei20; Xu, Jianming21; Du, Xiang1,2
刊名PLOS ONE
2013-11-14
DOI10.1371/journal.pone.0080290
8期:11
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Multidisciplinary Sciences
研究领域[WOS]Science & Technology - Other Topics
关键词[WOS]IN-SITU HYBRIDIZATION ; SCORING SYSTEM ; EXPRESSION ; MORTALITY ; VALIDATION ; ESOPHAGEAL ; CARCINOMA ; BREAST ; CARDIA
英文摘要

Trastuzumab has been approved for human epidermal growth factor receptor 2 (HER2)-positive advanced gastric and gastroesophageal junction cancers (GC and GJC) in combination with chemotherapy. The aim of this HER2 early/advanced gastric epidemiology (HER-EAGLE) study was to evaluate the frequency of HER2 over-expression and to evaluate agreement on HER2 status assessment in GC and GJC patients in local laboratories versus a central laboratory in China. Tumor samples from 734 GC or GJC patients who were enrolled at 11 different hospitals in China were examined. HER2 status was assessed by immunohistochemistry (IHC), and followed by dual-color silver-enhanced in Situ hybridization (DSISH) in IHC 2+ cases. Clinicopathologic characteristics were collected from all of the patients. HER2-positive tumors were identified in 12.0% (88/734) of the GC and GJC cases. There were significantly higher rates of HER2 positivity in patients with GJC (GJC: 18.1%, GC: 9.7%, P=0.002), and intestinal-type cancers using the Lauren classification (intestinal: 23.6%, diffuse/mixed: 4.3%, P<0.0001). No significant difference in HER2 positivity was identified between resection and biopsy samples, or between early and advanced disease stages. The agreement between local laboratories and the central laboratory on HER2 status scoring was good (kappa=0.86). The main reason of HER2 status discordance between local and the central laboratories was IHC result mis-interpretation in local laboratories. These results suggest that IHC followed by DSISH testing is an accurate and cost-effective procedure in China.

语种英语
WOS记录号WOS:000327143800140
资助机构Shanghai ROCHE pharmaceuticals Ltd.
引用统计
被引频次:21[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/60827
专题北京大学临床肿瘤学院_病理科
作者单位1.Jiangsu Prov Hosp, Dept Pathol, Nanjing, Jiangsu, Peoples R China
2.PLA Hosp, Dept Pathol, Nanjing, Jiangsu, Peoples R China
3.Beijing Canc Hosp, Dept Pathol, Beijing, Peoples R China
4.Zhejiang Canc Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China
5.PLA 307 Hosp, Dept Pathol, Beijing, Peoples R China
6.PLA Hosp, Dept Surg, Nanjing, Jiangsu, Peoples R China
7.PLA 307 Hosp, Dept Gastrointestinal Oncol, Beijing, Peoples R China
8.Fudan Univ, Ctr Canc, Dept Pathol, Shanghai 200433, Peoples R China
9.Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China
10.Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China
11.Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610064, Peoples R China
12.Shanghai Jiao Tong Univ, Sch Med, Ruijing Hosp, Dept Pathol, Shanghai 200030, Peoples R China
13.Guangdong Gen Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China
14.Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China
15.Sichuan Univ, West China Hosp, Ctr Gastrointestinal Surg, Chengdu 610064, Peoples R China
16.Shanghai Jiao Tong Univ, Sch Med, Ruijing Hosp, Dept Surg, Shanghai 200030, Peoples R China
17.Shanghai Jiao Tong Univ, Sch Med, Ruijing Hosp, Shanghai Inst Digest Surg, Shanghai 200030, Peoples R China
18.Guangdong Gen Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China
19.Beijing Canc Hosp, Dept Gastrointestinal Surg, Beijing, Peoples R China
20.Zhejiang Canc Hosp, Dept Abdominal Surg, Hangzhou, Zhejiang, Peoples R China
21.Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China
推荐引用方式
GB/T 7714
Huang, Dan,Lu, Ning,Fan, Qinhe,et al. HER2 Status in Gastric and Gastroesophageal Junction Cancer Assessed by Local and Central Laboratories: Chinese Results of the HER-EAGLE Study[J]. PLOS ONE,2013,8(11).
APA Huang, Dan.,Lu, Ning.,Fan, Qinhe.,Sheng, Weiqi.,Bu, Hong.,...&Du, Xiang.(2013).HER2 Status in Gastric and Gastroesophageal Junction Cancer Assessed by Local and Central Laboratories: Chinese Results of the HER-EAGLE Study.PLOS ONE,8(11).
MLA Huang, Dan,et al."HER2 Status in Gastric and Gastroesophageal Junction Cancer Assessed by Local and Central Laboratories: Chinese Results of the HER-EAGLE Study".PLOS ONE 8.11(2013).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Huang, Dan]的文章
[Lu, Ning]的文章
[Fan, Qinhe]的文章
百度学术
百度学术中相似的文章
[Huang, Dan]的文章
[Lu, Ning]的文章
[Fan, Qinhe]的文章
必应学术
必应学术中相似的文章
[Huang, Dan]的文章
[Lu, Ning]的文章
[Fan, Qinhe]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。